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Abstract
Background: The aim of this study was to assess the psychological consequences of HRCT scan screening in
retired asbestos-exposed workers.
Methods: A HRCT-scan screening program for asbestos-related diseases was carried out in four regions of France.
At baseline (T1), subjects filled in self-administered occupational questionnaires. In two of the regions, subjects also
received a validated psychological scale, namely the psychological consequences questionnaire (PCQ). The
physician was required to provide the subject with the results of the HRCT scan at a final visit. A second
assessment of psychological consequences was performed 6 months after the HRCT-scan examination (T2). PCQ
scores were compared quantitatively (t-test, general linear model) and qualitatively (chi²-test, logistic regression) to
screening results. Multivariate analyses were adjusted for gender, age, smoking, asbestos exposure and counseling.
Results: Among the 832 subjects included in this psychological impact study, HRCT-scan screening was associated
with a significant increase of the psychological score 6 months after the examination relative to baseline values
(8.31 to 10.08, p < 0.0001, t-test). This increase concerned patients with an abnormal HRCT-scan result, regardless of
the abnormalities, but also patients with normal HRCT-scans after adjustment for age, gender, smoking status,
asbestos exposure and counseling visit. The greatest increase was observed for pleural plaques (+3.60; 95%CI
[+2.15;+5.06]), which are benign lesions. Detection of isolated pulmonary nodules was also associated with a less
marked but nevertheless significant increase of distress (+1.88; 95%CI [+0.34;+3.42]). However, analyses based on
logistic regressions only showed a close to significant increase of the proportion of subjects with abnormal PCQ
scores at T2 for patients with asbestosis (OR = 1.92; 95%CI [0.97-3.81]) or with two or more diseases (OR = 2.04;
95%CI [0.95-4.37]).
Conclusion: This study suggests that HRCT-scan screening may be associated with increased distress in asbestos-
exposed subjects. If confirmed, these results may have consequences for HRCT-scan screening recommendations.
Background
Asbestos is responsible for both non-malignant diseases
such as pleural plaques and asbestosis and malignant
diseases such as mesothelioma and lung cancer [1].
Mesothelioma is known to occur even at low levels of
asbestos exposure. Recent publications have also
reported that lung cancer may occur in patients exposed
to asbestos at lower levels than previously demonstrated
[2]. Thoracic High Resolution Computed Tomography
(HRCT) has been clearly demonstrated to be more sen-
sitive and specific than Chest X-Rays for the diagnosis
of asbestos-related diseases even at early stages [3] and
for lung cancer [4]. The question of CT scan screening
for lung cancer is currently debated in both high-risk
populations exposed to tobacco smoke or occupational
carcinogens, as no definite proof of the benefit of such
screening has been published [5]. Recommendations for
potential applications of CT scan in lung cancer screen-
ing among asbestos-exposed subjects have been pub-
lished [6] and several lung cancer screening programs
have subsequently been reported [7,8]
To date, there is no evidence that any intervention can
modify the natural history of any asbestos-related condi-
tion, and therefore, that the necessary pre-conditions for
any screening programme have not been yet met. On
the other hand, French regulations lead to several
advantages to former workers suffering of an asbestos-
* Correspondence: christophe.paris@nancy.inserm.fr
1Nancy University Hospital, 54000 Nancy, France
Full list of author information is available at the end of the article
Paris et al. BMC Public Health 2010, 10:647
http://www.biomedcentral.com/1471-2458/10/647
© 2010 Paris et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.related disease such as compensations and the right to
an earlier retirement, even for pleural plaques. As a
result regarding these social advantages and despite the
absence of a medical benefit, screening of asbestos-
related diseases is recommended in France under some
specific criteria.
In this context, the impact of adverse effects such as
negative psychological impact in large screened popula-
tions may be important, particularly in view of the high
prevalence of false-positive results (namely benign iso-
lated pulmonary nodules requiring periodic survey) [9].
However, to date only a few data have been published
on the psychological consequences of CT scan lung can-
cer screening programs [10-12], reporting only minimal
distress at 6 months in ever smokers in relation to
screening. To the best of our knowledge, only one study
[13] has evaluated the possible psychological impact of
CT screening in asbestos-exposed subjects. This study
found no significant psychological differences one year
after CT scan between subjects who received clear
results at inclusion and those who were submitted to
additional examinations because of positive findings, in
a sample of 601 subjects surveyed for asbestos-related
diseases. Only sparse documentation is available regard-
ing the specific distress related to asbestos exposure.
Most of these previous studies reported the absence of
any observed psychological distress in subjects exposed
to asbestos [14,15]. Evaluation of the psychological
impact of CT-scan screening was one of the objectives
of the French multiregional asbestos-post exposure sur-
vey ordered by national authorities. We recently pub-
lished a study showing that asbestos-exposed subjects
exhibited significantly higher levels of negative psycholo-
gical impact compared to a control group at baseline of
a screening program [16].
We therefore hypothesized that the psychological
impact related to screening may be more pronounced in
this particular population. The aim of this study was to
assess the long-term psychological consequences of a
CT scan screening in the population of the asbestos
post-exposure survey (APExS).
Methods
The overall design of this study has been previously
published [16,17].
Global design
A large-scale screening program for asbestos-related dis-
eases (the Asbestos Post-Exposure Survey APEXS) was
carried out in four regions of France between October
2003 and December 2005. The target group for the
screening program comprised unemployed or retired
asbestos-exposed workers covered financially by French
National Health Insurance. Recruitment procedures
were based on television, newspapers, mailing or sys-
tematic invitations at national health insurance centers
in each region. All volunteer subjects were asked to
complete a standardized questionnaire describing all
jobs held throughout the subject’s working life, as well
as specific asbestos-exposing tasks. Questionnaires were
analyzed by industrial hygienists (IH) or trained national
health insurance agents depending on areas. The level of
exposure was defined for each subject’s entire career
and classified into four classes: high (defined as “contin-
uous exposure for at least one year” or “discontinuous
exposure for at least 10 years”), low (passive exposure),
moderate (all other occupational exposure) and nil (no
exposure). Only subjects with a reliable occupational
asbestos exposure as assessed by IH, regardless of the
level and occupational characteristics, and with no
known occupational asbestos-related disease were
invited to undergo a free screening program comprising
clinical examination and pulmonary function tests with
the chest physician of their choice, and chest X-rays and
spiral CT-scan performed by program-approved radiolo-
gists. A total of 20,157 subjects volunteered to partici-
pate in the APEXS and 16,885 subjects returned the
completed occupational questionnaire; 13,859 (82.1%) of
these subjects were eligible for the screening program in
terms of their National Health Insurance cover and
more than half of them (7,275; 52.5%) underwent chest
HRCT. Subjects whose HRCT reports were not sent to
the coordination center (n = 734) or who presented
incomplete data (n = 709), as well as non-exposed sub-
jects (n = 32), were excluded from further analysis.
Recommended HRCT acquisition parameters were
defined in accordance with the French Thoracic Imaging
Society guidelines. Radiologists who participated in the
program received guidelines on how to perform HRCT
for the diagnosis of asbestos-related benign diseases as
well as specific training in the interpretation of HRCT
from experienced radiologists and occupational physi-
cians. Recommendations were given for the survey of
isolated pulmonary nodules, according to the Fleishner
Society [18].
For the purposes of this study, the presence or
absence of radiological abnormalities (asbestos-related
diseases, pulmonary nodules with a diameter ≥ 5m m ,
other disorders) was rated only on the basis of HRCT
reports by radiologists blinded to clinical data. More
precise definitions are given elsewhere [17]. HRCT scan
results and counseling had to be given to the patient by
the general practitioner or the respiratory physician dur-
ing a final visit.
Study design
The present study, designed to investigate the psycholo-
gical impact of CT-scan screening, is an ancillary study
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subjects living in two of the four regions of the study
also received at baseline (defined as T1) together with
the occupational questionnaire, a specific questionnaire
to assess risk factors associated with asbestos exposure
distress. Subjects having sent both questionnaires but
with not known asbestos exposure were used as a con-
trol group for distress assessment. For the purposes of
this study, all patients consecutively enrolled between
December 2004 and December 2005 (n = 1184) with a
first recorded PCQ and an identified HRCT scan exami-
nation were invited to fill in the PCQ again, 6 months
after the date of the HRCT scan (defined as T2).
Among the 867 returns (73.2%), only 832 subjects com-
pletely filled in all the questionnaires.
Distress was measured using the Psychological Conse-
quences Questionnaire (PCQ). Initially developed by
Cockburn et al. [19]to assess the psychological conse-
quences of breast cancer screening by mammography,
the PCQ is a 12-item self-report instrument measuring
the effect of screening on the individual’s functioning on
emotional, physical and social life domains. A French
version of this scale has been validated by Maziade et al.
[20]. The PCQ was adapted for use in the present study
with slight modifications in its published form, as ques-
tions were asked in relation to asbestos-related diseases
in general (see online additional file 1). The response
options ranged from 0 (not at all) to 3 (quite a lot of
the time) and a score was calculated by summing each
response for each subscale and for the global scale. Each
study participant was asked to complete general charac-
teristics (age, gender, smoking status), self-perception of
current and future health status and their opinions and
knowledge about asbestos-related diseases. Self-assess-
ment by the subjects of the intensity asbestos exposure
was also used in the study.
The project was approved by the Cochin Hospital
ethics committee in Paris. All patients received informa-
tion on the study and gave their written informed con-
sent to the radiologist for the increased radiation dose
delivered by HRCT.
Statistical analysis
Only subjects for whom the two questionnaires were
available were included in the present analyses. Analyses
of the PCQ score used quantitative definitions (PCQ
values at T1, T2 and T2-T1 difference values) as well as
a qualitative approach. In order to obtain a reference
value for each gender, an abnormal global score was
defined as a value greater than the 95
th percentile of the
distribution of the PCQ scores calculated separately in
males (n = 210) and females (n = 226) with no asbestos
exposure in their own opinion as assessed by the initial
questionnaire. These subjects were derived from the
initial sample of volunteersf r o mt h es a m et w or e g i o n s .
This conservative calculation is independent of the dis-
tribution function of the score. Subjects were then clas-
sified into two categories (normal/abnormal) according
to their PCQ global score as previously published [16].
Analyses were conducted in order to describe PCQ
scores at baseline and during follow-up according to the
results of HRCT scan screening. Both univariate (t-test,
paired t-test, Chi-square and McNemar tests, as rele-
vant) and multivariate analyses (general linear model -
GLM -, logistic regression - LR -) were performed. In
every case, multiple models were adjusted for age, gen-
der, smoking status, self-assessment of asbestos expo-
sure and counseling. Power calculation showed a
statistical power of 99% for a 25% increase of the PCQ
score, but only 25% for an OR of 2.0, according to the
number of subjects with abnormal HRCT results. Data
were analyzed by SAS software (SAS Institute, release
9.2, USA).
Results
The study population comprised 92.3% males with a
mean age of 62 years; 9.1% of the subjects were smokers
(table 1). HRCT scan results were not available for 160
of the 832 patients (reports or CD-ROM not available in
the centers) and no abnormalities were found in another
213 patients. The remaining 459 patients (68.3% of
patients with a known HRCT scan result) presented at
least one lesion. Isolated pleural plaques were present in
113 patients (16.8%), isolated interstitial abnormalities
compatible with asbestosis were present in 67 subjects
(11.3%) and isolated pulmonary nodules were present in
79 subjects (11.8%). Other abnormalities mainly con-
sisted of emphysema, bronchial abnormalities, calcified
nodules or nonspecific sequelae.
According to our definition of abnormal PCQ score,
32.6% of subjects demonstrated an abnormal PCQ score
at T2 compared to 20.5% before screening (p < 0.001)
(Table 2). Moreover, 19.0% of the 661 subjects in whom
the PCQ score was considered to be normal at baseline
presented an abnormal PCQ score 6 months later (p <
0.0001, McNemar test). At baseline, only self-assessment
of exposure was significantly associated with the PCQ
score. At T2, an association was observed with this vari-
able, but also with smoking status. Patients who
attended a counseling visit had a significantly higher
score at baseline but not at T2. A significant increase of
PCQ score was observed for all categories of variables
except in females. The proportion of patients with an
abnormal PCQ score according to HRCT scan results
was higher than at T1, ranging from 26.8% (normal
HRCT scan) to 42.9% (two or more lesions) (Table 3).
The most marked increases in the proportion of patients
with an abnormal PCQ score were observed in patients
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(+26.5%, p = 0.0045, McNemar test), asbestosis (+26.9%,
p = 0.0067, McNemar test) and isolated pulmonary
nodules (+21.5%, p = 0.0105, McNemar test). Conver-
sely, 7.0% of subjects regained a normal PCQ score at
T2 (data not shown).
Follow-up of psychological impact showed a significant
increase of the quantitative PCQ score (p < 0.0001,
paired t-test). Baseline PCQ scores did not differ between
HRCT scan groups. At T2, using the PCQ score of
patients with normal CT scan as the reference, only
patients with pleural plaques detected by CT scan
showed a higher PCQ score (p = 0.0078, paired t-test).
However, when comparing subjects to themselves
between baseline and follow-up according to the results
of HRCT scan, all subjects with a known result, even nor-
mal, demonstrated a significant increase of their PCQ
score. The most marked increases of PCQ were observed
for patients with isolated pleural plaques, followed by
combinations of two or more lesions and abnormalities
compatible with asbestosis. The presence of isolated pul-
monary nodules was associated with a slight but signifi-
cant increase of PCQ (8.99 to 10.58, p = 0.027, paired t-
test) which was close to that observed in patients with
normal HRCT scans (8.02 to 9.28, p = 0.001, paired t-
test). Multivariate analyses taking gender, age, smoking
status and self-assessment ofa s b e s t o se x p o s u r ei n t o
account (Table 4) confirmed these findings. The increase
of PCQ score was significant in all patients with a known
result, and the most marked increase was observed for
subjects with pleural plaques (+3.60 [95%CI: +2.15,
+5.06], GLM). The presence of isolated pulmonary
nodules was associated with a significant increase of the
PCQ score of +1.88 [+0.34, +3.42], GLM). Even a normal
HRCT scan result was associated with a significant
increase (+1.40 [+0.11, +2.69], GLM). On pairwise com-
parisons, patients with pleural plaques demonstrated a
significantly higher increase of PCQ score than that
observed in patients with normal CT scan (p = 0.0042)
and close to significance for patients with other disorders
(p = 0.0597) or pulmonary nodules (p = 0.0734, data not
shown). Finally, variables associated with the risk of
developing an abnormal PCQ score according to our
definition were tested by logistic regressions (Table 5).
The presence of asbestosis and two or more diseases
were associated with an almost significant risk (OR 1.92
[0.97-3.81] and OR 2.04[0.95-4.37], respectively), after
adjustment for gender, age, smoking status, self-assess-
ment of asbestos exposure and a final counseling visit.
Discussion
Initial HRCT scan screening in this previously asbestos-
exposed population was associated with a significant
increase of the PCQ score 6 months after the examina-
tion. This increase, relative to baseline values, concerned
patients with an abnormal CT scan result, regardless of
the abnormalities, but also normal CT scans, after
adjustment for age, gender, smoking status self-assess-
ment of asbestos exposure and final counseling visit.
The most marked increase was observed in patients
with pleural plaques that are benign lesions. In contrast,
detection of isolated pulmonary nodules that may have
potentially more serious consequences on health status
was also associated with a less marked but significant
increase of distress. However, only the presence of
asbestosis or an association of two or more abnormal-
ities appeared to be associated with a clinically signifi-
cant modification of the PCQ score, although these
associations were not statistically significant.
Table 1 Description of the population (n = 832)
Variables N (%)
Gender
Male 768 (92.3)
Female 64 (7.7)
Age
< 60 years 328 (39.4)
60-74 years 455 (54.7)
≥ 75 years 49 (5.9)
Mean (SD) [Range] 62.27 (7.78)
[36.0-85.0]
Smoking status
Non-smoker 381 (45.8)
Former smoker 375 (45.1)
Smoker 76 (9.1)
Self-assessment of asbestos exposure
Nil/Light 94 (11.3)
Moderate 333 (40.0)
Heavy 216 (26.0)
Do not know 189 (22.7)
Counseling visit
No 268 (32.2)
yes 564 (67.8)
CT scan results
Normal 213 (25.6)
Abnormal 459 (55.2)
Isolated pulmonary nodules (only) 79 (9.5)
Pleural plaques (only) 113 (13.6)
Asbestosis (with or without pleural
plaques)
67 (8.0)
Other diseases (only) 151 (18.1)
Two or more of the above diseases 49 (5.6)
Unknown results 160 (19.2)
Results are expressed as means and SD (age) or as numbers and percent
(other variables) as relevant.
Paris et al. BMC Public Health 2010, 10:647
http://www.biomedcentral.com/1471-2458/10/647
Page 4 of 10Table 2 Comparison of the 3 subscales and global PCQ score at baseline and during follow-up according to
descriptive variables
Baseline Follow-up P value
1
PCQ Score
Social dimension score 2.67 (2.50-2.83) 3.36 (3.16-3.56) P < 0.0001
Physical dimension score 2.61 (2.48-2.75) 3.23 (3.08-3.39) P < 0.0001
Emotional dimension score 3.01 (2.87-3.15) 3.47 (3.32-3.62) P < 0.0001
Global PCQ score 8.30 (7.91-8.69) 10.07 (9.62-10.53) P < 0.0001
Abnormal PCQ score² 171 (20.6) 271 (32.6) P < 0.0001
Acquiring abnormal PCQ score² at T2 158 (19.0)
3
Gender
Males 8.24 (7.83-8.64) 10.11 (9.63-10.58) P < 0.0001
Females 9.07 (7.67-10.47) 9.68 (8.03-11.33) P = 0.4949
P = 0.2601
4 P = 0.6278
4
Smoking status
Non-smokers 8.23 (7.65-8.80) 9.85 (9.18-10.50) P < 0.0001
Former smokers 8.13 (7.55-8.71) 9.76 (9.08-10.43) P < 0.0001
Smokers 9.52 (8.24-10.80) 12.75 (11.24-14.25) P < 0.0001
P = 0.1437
4 P = 0.0013
4
Counseling visit
Yes 8.03 (7.65-8.20) 9.98 (9.42-10.53) P < 0.0001
No 8.88 (8.20-9.56) 10.29 (9.48-11.10) P = 0.0002
P = 0.0439
4 P = 0.5244
4
Self-assessment of asbestos exposure
Nil/light 6.14 (5.00-7.27) 7.44 (6.12-8.76) P = 0.0074
Moderate 7.97 (7.37-8.57) 9.06 (8.35-9.76) P = 0.0003
Heavy 9.96 (9.21-10.71) 12.43 (11.55-13.29) P < 0.0001
Do not know 8.08 (7.28-10.27) 10.50 (9.56-11.53) P < 0.0001
P < 0.0001
4 P < 0.0001
4
1: comparison of PCQ scores at baseline and during follow-up by t-test.
2: PCQ values greater than the 95
th percentile of the PCQ score distribution in non-exposed subjects (see ref [16].
3: among the 661 subjects without an abnormal PCQ score at baseline.
4: comparison of PCQ scores between variables at each time-point of the study by GLM.
Table 3 Course of PCQ scores and proportions of subjects with abnormal PCQ score
abetween T1 and T2 according to
the HRCT scan results (n = 832, univariate analyses)
At T1 At T2 Variation
CT scans N Abnormal
PCQ
a N (%)
Mean
PCQ
P value
b Abnormal
PCQ
a N (%)
Mean
PCQ
P value
b Acquiring
Abnormal
PCQ
a N (%)
P
value
c
Mean
PCQ
d
P
value
e
Normal 213 44 (20.7) 8.02 Reference 57 (26.8) 9.28 Reference 31 (14.6) 0.0633 +1.26 0.0010
Isolated pulmonary
Nodules (only)
79 15 (19.0) 8.99 0.2019 27 (34.2) 10.58 0.1497 17 (21.5) 0.0105 +1.59 0.0276
Pleural plaques (only) 113 21 (18.6) 7.77 0.6972 40 (35.4) 11.24 0.0078 24 (21.2) 0.0004 +3.47 <0.0001
Asbestosis (with or
without pleural plaques)
67 13 (19.4) 8.40 0.9280 26 (38.8) 10.64 0.1303 18 (26.9) 0.0067 +2.24 0.0005
Other diseases (only) 151 28 (18.5) 8.38 0.5490 53 (35.1) 10.19 0.2037 32 (21.2) <
0.0001
+1.80 0.0002
Two or more of the above
lesions
49 10 (20.4) 7.73 0.7504 21 (42.9) 10.86 0.1202 13 (26.5) 0.0045 +3.12 0.0002
Unknown results 160 40 (25.0) 8.79 0.2131 47 (29.4) 9.50 0.7556 23 (14.4) 0.2623 +0.71 0.1394
aPCQ values greater than the 95
thpercentile of the PCQ score distribution in non-exposed subjects (see ref [16]).
bComparison of the PCQ score at baseline (t-test)
cComparison of the proportion of abnormal PCQ scores between T1 and T2 for each HRCT scan result (McNemar test).
dΔPCQ is defined as the PCQ at T2 - PCQ at T1 difference.
eComparison between PCQ score at baseline and during follow-up for each HRCT scan result (paired t-test).
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cer screening on quality of life or distress at so-called
“short-term” (usually < 3 months) or “long-term” (at 6
or 12 months depending on the studies). Not surpris-
ingly, positive cancer screening can lead to anxiety [21].
Conversely, negative screening with a clear result is
t h o u g h tt ob ea s s o c i a t e dw i t ho n l ym i n i m a la n dt r a n s i -
ent psychological impact [22-25]. It is well known that
patients with lung cancer present a high rate of depres-
sion, with an average of 25% according to the review by
Carlsen et al. [26]. However, to our knowledge, only two
studies have evaluated the possible psychological conse-
quences of lung cancer screening. Van den Berg [12]
studied the effect of lung cancer screening in 351 sub-
jects, at baseline, 1 day after the examination and 6
months later. Psychological impact was assessed using
the Spielberger State-Trait Anxiety inventory (STAI-6),
t h e1 2 - i t e mS h o r tF o r m( S F - 1 2 )a n dI m p a c to fE v e n t
Scale (IES). No significant effect was seen between nega-
tive screening at baseline and negative repeated CT scan
at 6 months. In the second study [11], 341 subjects were
questioned four times (pre- and post-screening, 6 and
12 months) using the STAI and 3 questions of the PCQ.
Patients with indeterminate results (namely one or more
pulmonary nodule with advice to perform periodic sur-
vey) presented a significant increase in negative psycho-
logical measures immediately following screening,
although these findings faded with time. No effect (posi-
tive or negative) was observed in subjects with negative
screening. Vierikko et al. recently reported no significant
negative psychological impact in subjects exposed to
asbestos during the one-year survey of positive CT scan
findings [13].
The results of our study differ from these findings,
which are nevertheless difficult to interpret. Our study
shows a significant increase of long-term distress as
assessed by the PCQ score in patients in whom CT scan
revealed an asbestos-related disease, and to a lesser
extent, an isolated pulmonary nodule. Identical results
have sometimes been reported for other types of cancer
Table 4 Main determinants of a significant variation of the PCQ score during follow-up (multivariate analysis, general
linear model; n = 832)
Variables ΔPCQ
a,b Mean increase 95% CI P value
Gender - 0.1678
Males + 2.75 1.95, +3.54
Females +1.64 -0.05, +3.33
Smoking status - 0.0646
Non smokers +1.71 +0.71, +2.71
Former Smokers +1.70 +0.57, +2.83
Smokers +3.17 +1.49, +4.85
Age (years) - 0.7027
<6 0 +1.91 +0.91, +2.91
60-75 +1.99 +0.95, +3.04
>7 5 +2.67 +0.78, +4.57
Self-assessment of asbestos exposure - 0.0095
Nil/light +1.69 +0.11, +3.26
Moderate +1.38 +0.22, +2.55
Heavy +2.86 +1.64, +4.08
Do not know +2.84 +1.60, +4.07
Counseling visit 0.2942
No +1.96 +0.75, +3.16
Yes +2.43 +1.34, +3.52
CT scan results - 0.0039
Normal +1.40 +0.11, +2.69
Isolated pulmonary nodules (only) +1.88 +0.34, +3.42
Pleural plaques (only) +3.60 +2.15, +5.06
Asbestosis (with or without pleural plaques) +2.52 +0.80, +4.24
Other diseases (only) +1.76 +0.46, +3.06
Two or more of the above lesions +3.37 +1.39, +5.34
Unknown results +0.83 -0.50, +2.17
a ΔPCQ is defined as the PCQ at T2-PCQ at T1 difference
b Means are adjusted for gender, age, smoking status, counseling visit and self-assessment of asbestos exposure
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tions can be proposed for these discrepancies. First, our
study used a scale developed for a breast cancer screen-
ing program by mammography [19]. The choice to use
this scale was primarily dictated by the aim of the study
to assess the psychological consequences of radiological
screening by HRCT scan in this population, and the
existence of a validated French version of the scale. To
our knowledge, no specific scale is available for the
assessment of the psychological impact of CT scan
screening for lung cancer or asbestos-related diseases.
Recently published studies on the impact of CT scan
screening for lung cancer used nonspecific quality-of-life
scales. As stated by the autho r st h e m s e l v e s[ 1 1 , 1 2 ] ,
these scales may be insensitive with regard to measure-
ment of the specific impact of screening and some
authors have recommended that these scales not be
used for cancer screening [27]. Conversely, the authors
of the PCQ considered that their tool can be used for a
wide range of radiographic screening, as the PCQ scale
explores three important dimensions of mental func-
tions [19]. Our results support the hypothesis that most
of the negative results concerning the psychological
impact of screening may be due to the poor sensitivity
of the scales used. One difficulty of the PCQ (as for
other scales) is the absence of normal values for clinical
interpretation [28]. Both univariate analyses using our
definition of patients with an abnormal score or quanti-
tative values of PCQ scores clearly showed positive asso-
ciations between increasing distress and HRCT scan
results, in contrast with published data. As an abnormal
PCQ score was defined as a score greater than the 95th
percentile in our reference group [16], we hypothesize
that the psychological consequences associated with
HRCT scan screening may affect quality of life in a size-
able proportion of subjects. Finally, the clinical signifi-
cance of these results is difficult to determine, in view
of the difference observed between multivariate GLM
and LR models. Tested hypotheses and the statistical
power, which clearly differed between the two statistical
approaches, may easily explain these discordant results.
As previously underlined, only one study has been con-
ducted in an asbestos-exposed population with different
results. However, this study used different tools to assess
psychological consequences and a large proportion of
the subjects of this study were surveyed over a long
time, which may explain these discrepancies. Surpris-
ingly, the presence of a counseling visit had no effect on
psychological impact in our study [13]. Some authors
have reported that distress may be modified by the per-
ception of cancer risk for breast cancer screening
[29,30] but also in lung cancer [31]. It can be hypothe-
sized that the existence of asbestos exposure could lead
to a greater fear of the consequences of screening in
this particular population without any previous screen-
ing. The high level of distress observed at baseline in
o u rs t u d y[ 1 6 ]s u p p o r t st h i sh y p o t h e s i sa sw e l la st h e
increase associated with self-assessment of exposure.
The slight but significant difference observed between
subjects before attending a final visit also suggested a
selection bias related to patients attending this visit. On
the other hand, former smokers and especially current
smokers enrolled in CT scan screening are thought to
usually underestimate their risk of lung cancer [31,32].
Our findings obviously cannot be generalized to popula-
tions suitable for lung cancer screening, and further stu-
dies among ever smokers are needed to confirm our
results. In particular, the role of perception of cancer
risk in both asbestos-exposed subjects and ever smokers
needs to be investigated.
Table 5 Main determinants of acquiring an abnormal
PCQ score
1 during follow-up (multivariate analysis,
logistic regression model; n = 832)
Variables
OR [95% CI] P
value
Gender
Males 1 reference
Females 0.88 [0.42-1.85] 0.7340
Age
< 60 years 1 reference
60-74 years 1.14 [0.76-1.70] 0.5125
> = 75 years 1.75 [0.83-3.54] 0.1675
Smoking
Non-Smoker 1 reference
Former Smoker 0.91 [0.62-1.36] 0.0577
Smoker 1.83 [1.00-3.34] 0.0242
Counseling (yes)
No 1 reference
Yes 1.35 [0.90-2.04] 0.1442
Exposure
Nil/light 1 reference
Moderate 1.24 [0.61-2.51] 0.0901
Heavy 2.34 [1.14-7.79] 0.0178
Do not Know 2.31 [1.12-4.77] 0.0275
CT Scan Results
Normal 1 reference
Isolated pulmonary nodules (only) 1.68 [0.86-3.31] 0.1313
Pleural plaques (only) 1.46 [0.79-2.69] 0.2315
Asbestosis (with or without pleural
plaques)
1.92 [0.97-3.81] 0.0608
Other diseases (only) 1.49 [0.85-2.62] 0.1633
Two or more of the above diseases 2.04 [0.95-4.37] 0.0673
Unknown results 0.99 [0.53-1.83] 0.9775
1: Values of PCQ greater than the 95
th percentile of the PCQ score distribution
in non-exposed subjects (see ref [16]).
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found in patients with normal HRCT scan after adjust-
ment for gender, age, smoking status, counseling and
self-assessment of asbestos exposure. These results have
sometimes been reported in other screening studies for
breast cancer [33] but not in lung cancer. Particular
attention is required to explain these findings, if they
are confirmed.
Several limitations of this study need to be discussed.
First of all, the increase in PCQ score observed in our
population may not be clinically relevant, as no compar-
ison with a control group of exposed subjects without
HRCT was possible. In order to explore this limitation,
we investigated subjects with no identified HRCT scan,
but with a T2 PCQ questionnaire (after an interval of
one year). Seventy-four patients were therefore retrieved
and analyzed, showing no significant increase of their
PCQ score (8.31 at T1 versus 9.20 at T2, p = 0.2452,
data not shown). Analysis of our data using this group
as reference instead of patients with normal HRCT scan
results did not modify our main findings. Finally, no sig-
nificant differences were observed between subjects for
the baseline PCQ score before HRCT. As patients were
compared to themselves at T2, observed differences
were more likely to be related to HRCT results than to
subject-related factors. However, a misclassification of
this population cannot be excluded and these findings
must be confirmed by another study using an appropri-
ate control group.
Secondly, subjects volunteered to participate in the
survey which could lead to a selection bias. In order to
verify this hypothesis, we compared the PCQ score at
baseline among respondents versus non-respondents to
the survey, according to the presence or absence of a
HRCT scan examination and found no statistical differ-
ences between these groups of subjects. Moreover, com-
parisons of PCQ score at baseline according to HRCT
scan results showed no difference even with subjects
who did not undergo CT scan (data not shown). We
can therefore assume that, if it exists, a selection bias
relative to psychological distress at baseline would have
only a minimal effect on our results. On the other hand,
HRCT scan results were not available for 160 patients.
We reanalyzed our data assuming that all unknown
HRCT scan results were normal. This analysis did not
modify our results, particul a r l yf o rt h es i g n i f i c a n t
increase of PCQ score associated with normal HRCT
scan results in multivariate analysis (data not shown).
A second point concerns the interval between HRCT
scan examination and the second PCQ, fixed by the
design at 6 months (as usually defined in the literature
by “long-term”). This relatively long interval, albeit
similar to that of other studies, may result in changes
in health status, that may influence the second assess-
ment of psychological impact, independently of the
results of the initial HRCT scan. In order to minimize
this possible bias, we reviewed our data after excluding
patients with known cancer (lung cancers and
mesotheliomas, 8 subjects) during follow-up. No
changes in our results were observed. Variability in
measurement of PCQ score also did not appear to be
an explanation, as this score is considered to be repro-
ducible [19,20]. However, anxiety scores may be
affected by various other factors, even time, and a
longer survey with more complete questionnaires,
including general health questionnaires, would be use-
ful. The development of a specific scale for asbestos-
related health effects should be considered.
Finally, the definition used for HRCT scan results can
also be questioned. For instance, the diagnosis of asbes-
tosis is probably overestimated in these elderly subjects
with nonspecific interstitial abnormalities. However, we
decided to rate the presence of radiographic abnormal-
ities on the basis of radiology reports, which allow more
accurate assessment of the diagnosis given to the
patients than a standardized and independent
interpretation.
Conclusion
This study reported that HRCT scan screening is asso-
ciated with a long-term increase of distress in asbestos-
exposed subjects. The most marked increase was
observed for patients with pleural plaques that are con-
sidered to be a benign disease with no clinical conse-
quences. According to previous results, this may suggest
that asbestos workers have a specific and probably
poorer perception of cancer risk than the general popu-
lation, but these results must be confirmed in future
studies in view of the difficulty of estimating the clinical
significance of our findings. No clear guidelines have
been established for screening for asbestos-related dis-
eases, as no medical benefit has yet been demonstrated.
Clear and specific information on CT scan screening
and asbestos-related diseases must therefore be given to
subjects before and after the examination in the context
of individual screening. The possibility of psychological
management must also be discussed with patients. A
slight but significant increase of distress was also
observed after normal HRCT scan results and detection
of isolated pulmonary nodules in this population. These
findings need to be studied further in subjects not
exposed to asbestos. If confirmed, these results may
have consequences for the CT scan screening for lung
cancer, under the condition that current assessments of
these programs provide any proof of the existence of a
clear clinical benefit.
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Additional file 1: PCQ questionnaire. This file provides the PCQ
questionnaire as used in this study, adapted from Cockburn et al. Note
that the questions and the 3 axis have not been modified
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